Edan, Gilles

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 6,969

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 5,017

Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 963

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Epidemiology of multiple sclerosis

Leray, E., Moreau, T., Fromont, A., & Edan, G. (2016) · Revue Neurologique

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 478

Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study

Stankoff, B., Waubant, E., Confavreux, C., Edan, G., Debouverie, M., Rumbach, L., Moreau, T., Pelletier, J., Lubetzki, C., Clanet, M., et al. (2005) · Neurology

Multiple Sclerosis Research StudiesSleep and Work-Related Fatigue

Cited by 318

Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase

Kerbrat, A., Ferré, J.-C., Fillatre, P., Ronzière, T., Vannier, S., Carsin-Nicol, B., Lavoué, S., Vérin, M., Gauvrit, J.-Y., Le Tulzo, Y., et al. (2016) · New England Journal of Medicine

Cannabis and Cannabinoid ResearchNeurological Complications and Syndromes

Cited by 171

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients

Ayrignac, X., Carra-Dalliere, C., Menjot de Champfleur, N., Denier, C., Aubourg, P., Bellesme, C., Castelnovo, G., Pelletier, J., Audoin, B., Kaphan, E., et al. (2015) · Brain

Cerebrovascular and genetic disordersMetabolism and Genetic Disorders

Cited by 74

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Manuel Escobar, J., Cortese, M., Edan, G., Freedman, M. S., Hartung, H.-P., Montalbán, X., Sandbrink, R., Radü, E.-W., Barkhof, F., Wicklein, E.-M., et al. (2022) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 38

Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome

Maarouf, A., Ferré, J.-C., Zaaraoui, W., Le Troter, A., Bannier, E., Berry, I., Guye, M., Pierot, L., Barillot, C., Pelletier, J., et al. (2016) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesAdvanced MRI Techniques and Applications

Cited by 22

Improving the Quality of Life of Multiple Sclerosis Patients through Coping Strategies in Routine Medical Practice

Devy, R., Lehert, P., Varlan, E., Genty, M., & Edan, G. (2015) · Neurological Sciences

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 11